Updates are available Correction dated 2025-02-25
Click to view Correction: https://doi.org/10.1038/s41598-025-90967-4
-
Authors
Jeong, Jin Sook
Noh, Yunha
Cho, Sun Wook
Hsieh, Cheng-Yang
Cho, Yongtai
Shin, Ju-Young https://orcid.org/0000-0003-1010-7525
Kim, Hoon
-
Funding
Funding for this research was provided by:
Ministry of Food and Drug Safety (Ministry of Food and Drug Safety)
- License Information
-
More Information
Article History
Received: 25 September 2024
Accepted: 27 November 2024
First Online: 28 December 2024
Change Date: 25 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-025-90967-4
Declarations
:
: JYS received grants from the Ministry of Food and Drug Safety, the Ministry of Health and Welfare, the National Research Foundation of Korea, the Government-wide R&D Fund for Infectious Disease Research, and pharmaceutical companies, including Daiichi Sankyo, GSK, and Pfizer, outside the submitted work. YN received grants from the Ministry of Health and Welfare, outside the submitted work. SWC is a CEO/founder of Cellus, inc., outside the submitted work. HK has received research funds from JW Pharmaceutical, outside the submitted work. JSJ, CYH, and YC declare no competing interests. No other relationships or activities that could have influenced the submitted work.
: Due to the retrospective nature of the study, the Institutional Review Board of Sungkyunkwan University waived the need of obtaining informed consent.
: This study was approved by the Institutional Review Board of Sungkyunkwan University (No. SKKU 2020-12-002), which waived the requirement for informed consent as only de-identified data was used.
